Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

2.

Outpatient antibiotic therapy for elderly patients. HIAT Study Group.

Angel JV.

Am J Med. 1994 Aug 15;97(2A):43-9.

PMID:
8059801
6.

Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients.

Morales JO, Snead H.

Am J Med. 1994 Aug 15;97(2A):28-33.

PMID:
8059798
9.

Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.

Nichols RL, Smith JW, Geckler RW, Wilson SE.

South Med J. 1995 Apr;88(4):397-404. Erratum in: South Med J 1995 Jun;88(6):634.

PMID:
7716590
10.

Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.

Gentry LO, Ramirez-Ronda CH, Rodriguez-Noriega E, Thadepalli H, del Rosal PL, Ramirez C.

Arch Intern Med. 1989 Nov;149(11):2579-83.

PMID:
2684078
11.

A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.

Gentry LO, Rodriguez-Gomez G, Zeluff BJ, Khoshdel A, Price M.

Am J Med. 1989 Dec 29;87(6C):57S-60S.

PMID:
2690621
12.

Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections.

Lentino JR, Stachowski M, Strikas R, Parrillo P.

Antimicrob Agents Chemother. 1984 Jun;25(6):778-80.

15.

Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.

Ramirez-Ronda CH, Saavedra S, Rivera-Vázquez CR.

Am J Med. 1987 Apr 27;82(4A):220-3.

PMID:
3555040
16.

Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.

Pérez-Ruvalcaba JA, Quintero-Pérez NP, Morales-Reyes JJ, Huitrón-Ramírez JA, Rodríguez-Chagollán JJ, Rodríguez-Noriega E.

Am J Med. 1987 Apr 27;82(4A):242-6.

PMID:
3555042
17.

Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.

Ektare V, Khachatryan A, Xue M, Dunne M, Johnson K, Stephens J.

J Med Econ. 2015;18(12):1092-101. doi: 10.3111/13696998.2015.1078339. Epub 2015 Sep 14.

PMID:
26368787
18.

Ambulatory antibiotic infusion devices: extending the spectrum of outpatient therapies.

New PB, Swanson GF, Bulich RG, Taplin GC.

Am J Med. 1991 Nov;91(5):455-61.

PMID:
1951407
19.

Home intravenous antibiotic therapy. A safe and effective alternative to inpatient care.

Grayson ML, Silvers J, Turnidge J.

Med J Aust. 1995 Mar 6;162(5):249-53.

PMID:
7891605
20.

[Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections].

Manncke K, Springsklee M, Heizmann WR, Sonntag HG.

Med Klin (Munich). 1991 Sep 15;86(9):454-60. German.

PMID:
1943983

Supplemental Content

Support Center